Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide
- 1 December 2017
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 108, 115-127
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32ES007148, P30ES005022, R01ES021800, R01NS088627, R21DE025689, R01NS088267)
- Michael J Fox Foundation for Parkinson's Disease Research
- Allan and Janice Woll
- Richard Nicely
- Glenn and Karen Leppo Parkinson's Disease Research Funds
This publication has 82 references indexed in Scilit:
- The clinical symptoms of Parkinson's diseaseJournal of Neurochemistry, 2016
- The dynamics of monocytes and microglia in Alzheimer’s diseaseAlzheimer's Research & Therapy, 2015
- Neuroinflammation and M2 microglia: the good, the bad, and the inflamedJournal of Neuroinflammation, 2014
- Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2012
- Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3Proceedings of the National Academy of Sciences, 2011
- Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 miceJournal of Neuroscience Research, 2009
- Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative DiseaseBiological Psychiatry, 2009
- A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson DiseaseClinical Neuropharmacology, 2008
- Behavior, neurochemistry and histology after intranigral lipopolysaccharide injectionNeuroReport, 2002
- Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitudeActa Neuropathologica, 2001